Active not recruitingNAINTERVENTIONAL

Receiving Radiation Therapy in the MRgRT Research Facility

This study is happening at the Princess Margaret Cancer Centre and is about a new way of giving radiation treatment called Magnetic Resonance-guided Radiation Therapy (MRgRT). We want to understand how well this new equipment works and how smoothly the treatment process goes for the doctors, nurses, and other staff involved. This is important for people who have solid tumours or cancer that has spread to other parts of the body. The goal is to make sure the technology is performing at its best and that the clinic team can use it effectively to deliver the best possible care. It's not testing a new drug, but rather looking at the technology and the way the treatment is given.

At a glance

Status

Active not recruiting

Phase

Sponsor

University Health Network, Toronto

Enrolment target

150

Start

01 Feb 2016

Estimated completion

01 Feb 2027

Solid Tumors and Metastatic Lesions

What is this study about?

This study focuses on a special type of radiation therapy called Magnetic Resonance-guided Radiation Therapy, or MRgRT. Imagine traditional radiation therapy, but with a super-smart guidance system. This system uses magnetic resonance (like an MRI scan) to get a very clear, live picture of your body while the radiation is being delivered. This helps the medical team aim the radiation more precisely at the tumour, potentially sparing healthy tissue around it.

The main goal of this particular study is to see how well this MRgRT equipment works at the Princess Margaret Cancer Centre. They want to check its technical performance – fancy words for making sure all the parts are doing their job correctly and efficiently. They're also looking at how this new technology affects the everyday work of the clinical team. This means observing how easy or difficult it is for the doctors, nurses, and technicians to use the system, and if it changes how they plan and deliver treatments.

This is important because advanced technology like MRgRT aims to make radiation treatment more effective and safer. By understanding how the equipment performs and how the team uses it, researchers can help improve the treatment process for many patients with solid tumours or cancers that have spread to other areas of the body.

Key takeaways

This study is about making radiation treatment more precise and effective.
It focuses on how new MR-guided technology works in a cancer centre.
Participation involves no extra tests or appointments, just observation of routine treatment.
Aims to improve care for people with solid tumours or metastatic cancer.
You must be 18 or older and planning to use MRgRT technology for your care.
Helps advance the use of modern radiation therapy for future patients.

Who may be eligible?

To be part of this study, you would need to be at least 18 years old. You also need to be planning to receive some kind of treatment or imaging (like a scan) within the MRgRT facility itself. This means the study is for patients who are already going to be using this specific technology as part of their care.

Before joining, you'll need to understand what the study involves and agree to take part by signing a form. This is called giving 'informed consent'. Apart from these points, there aren't any other strict rules about who can't join this particular study. Both men and women are welcome.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Are you planning to have treatment or a scan using the MRgRT facility?
Can you understand information about the study and agree to take part?
Are you receiving treatment for a solid tumour or cancer that has spread?

Answer every question to see your result.

What does participation involve?

Taking part in this study means that your routine medical care using the MRgRT facility will be observed. You won't be asked to do anything extra outside of your planned treatment or imaging. There are no additional visits, assessments, or medications involved purely for the study. The researchers will simply be gathering information about how the MRgRT technology works and how the medical team uses it during your planned appointments. The duration of your involvement would typically match the length of your planned treatment or imaging schedule at the facility. There is no specific follow-up just for the study; your medical team will continue to follow your health as they normally would.

Potential risks and benefits

Since this study observes routine care, there are no additional risks beyond those of your standard MRgRT treatment. The potential benefit is that by participating, you help the medical team improve the way this advanced radiation therapy is delivered, which could benefit future patients. You are free to decide not to take part or to withdraw from the study at any time without it affecting your medical care.

Locations (1)

University Health Network
Verified postcode
Toronto, Canada

Common questions

What is MR-guided radiation therapy (MRgRT)?

It's a way of giving radiation treatment using special MRI-like scans live during treatment to help doctors aim the radiation very accurately at the tumour.

Do I have to do anything extra if I join this study?

No, you won't have any extra appointments, tests, or medicines. The study simply observes your routine treatment if you're already receiving care with MRgRT.

Who is running this study?

The study is being run by researchers at the Princess Margaret Cancer Centre.

Will taking part affect my cancer treatment?

No, your cancer treatment will continue as planned, whether or not you join the study. Joining won't change your care.

What kind of conditions are included in this study?

The study includes patients who have solid tumours or cancer that has spread to different parts of the body, and who are receiving treatment in the MRgRT facility.